Literature DB >> 35191993

[Revised German guidelines on the diagnosis and treatment of carcinoma of the uterine cervix-what's new for pathologists in 2021?]

Lars-Christian Horn1, Matthias W Beckmann2, Markus Follmann3, Martin C Koch4, Monika Nothacker5, Birgit Pöschel6, Frederik Stübs2, Dietmar Schmidt7, Anne Kathrin Höhn8.   

Abstract

In 2021, the 2015 German consensus guideline for the diagnosis and treatment of uterine cervical carcinoma was updated. The present article summarises the new recommendations for pathologists: the incorporation of the International Endocervical Adenocarcinoma Classification (IECC), which morphologically separates HPV-associated and non-HPV-associated adenocarcinomas, as well as the reporting of the prognostic relevant growth pattern of the adenocarcinoma of the endocervical subtype (Silva pattern). Histologically, multifocality has been defined as the presence of clearly invasive foci with a minimum distance between each focus of 0.2 cm. Because of its intratumoural heterogeneity, all carcinomas ≤ 2 cm in their largest dimension should be processed completely, and tumours > 2 cm should be processed with one block per centimetre of their greatest dimension. In cases of (radical) trachelectomy/hysterectomy, the distal vaginal resection margin and all parametrial tissue should be processed completely. Sentinel lymph nodes have to be processed completely by lamellation along its long axis in 0.2 cm intervals. Immunohistochemical ultrastaging is mandatory. Staging should be performed using the 2009 FIGO classification and 2017 TNM classification. Reporting the revised 2018 FIGO classification is optional. To date, molecular markers have not been relevant for prognostication and treatment decision making.
© 2022. The Author(s).

Entities:  

Keywords:  Cutting; Diagnostic; Workup

Mesh:

Year:  2022        PMID: 35191993     DOI: 10.1007/s00292-021-01051-3

Source DB:  PubMed          Journal:  Pathologie (Heidelb)        ISSN: 2731-7188


  60 in total

1.  Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.

Authors:  Tjalling Bosse; Elke E M Peters; Carien L Creutzberg; Ina M Jürgenliemk-Schulz; Jan J Jobsen; Jan Willem M Mens; Ludy C H W Lutgens; Elzbieta M van der Steen-Banasik; Vincent T H B M Smit; Remi A Nout
Journal:  Eur J Cancer       Date:  2015-06-03       Impact factor: 9.162

2.  Cervical conization and sentinel lymph node mapping in the treatment of stage I cervical cancer: is less enough?

Authors:  Vaagn Andikyan; Fady Khoury-Collado; John Denesopolis; Kay J Park; Yaser R Hussein; Carol L Brown; Yukio Sonoda; Dennis S Chi; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Int J Gynecol Cancer       Date:  2014-01       Impact factor: 3.437

Review 3.  Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables.

Authors:  Angiolo Gadducci; Maria Elena Guerrieri; Stefania Cosio
Journal:  Crit Rev Oncol Hematol       Date:  2019-01-19       Impact factor: 6.312

Review 4.  Cervical cancer.

Authors:  Paul A Cohen; Anjua Jhingran; Ana Oaknin; Lynette Denny
Journal:  Lancet       Date:  2019-01-12       Impact factor: 79.321

5.  The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.

Authors:  David Cibula; Richard Pötter; François Planchamp; Elisabeth Avall-Lundqvist; Daniela Fischerova; Christine Haie Meder; Christhardt Köhler; Fabio Landoni; Sigurd Lax; Jacob Christian Lindegaard; Umesh Mahantshetty; Patrice Mathevet; W Glenn McCluggage; Mary McCormack; Raj Naik; Remi Nout; Sandro Pignata; Jordi Ponce; Denis Querleu; Francesco Raspagliesi; Alexandros Rodolakis; Karl Tamussino; Pauline Wimberger; Maria Rosaria Raspollini
Journal:  Int J Gynecol Cancer       Date:  2018-05       Impact factor: 3.437

Review 6.  Revised FIGO staging for carcinoma of the cervix uteri.

Authors:  Neerja Bhatla; Jonathan S Berek; Mauricio Cuello Fredes; Lynette A Denny; Seija Grenman; Kanishka Karunaratne; Sean T Kehoe; Ikuo Konishi; Alexander B Olawaiye; Jaime Prat; Rengaswamy Sankaranarayanan; James Brierley; David Mutch; Denis Querleu; David Cibula; Michael Quinn; Hennie Botha; Lax Sigurd; Laurel Rice; Hee-Sug Ryu; Hextan Ngan; Johanna Mäenpää; Andri Andrijono; Gatot Purwoto; Amita Maheshwari; Uttam D Bafna; Marie Plante; Jayashree Natarajan
Journal:  Int J Gynaecol Obstet       Date:  2019-01-17       Impact factor: 3.561

7.  Multifocal FIGO Stage IA1 Squamous Carcinoma of the Cervix: Criteria for Identification, Staging, and its Good Clinical Outcome.

Authors:  Elizabeth Day; Siobhan Duffy; Gareth Bryson; Sheeba Syed; Smruta Shanbhag; Kevin Burton; Rhona Lindsay; Nadeem Siddiqui; David Millan
Journal:  Int J Gynecol Pathol       Date:  2016-09       Impact factor: 2.762

8.  Micropapillary Cervical Adenocarcinoma: A Clinicopathologic Study of 44 Cases.

Authors:  Isabel Alvarado-Cabrero; W Glenn McCluggage; Rafael Estevez-Castro; Delia Pérez-Montiel; Simona Stolnicu; Raji Ganesan; Josefa Vella; Rosario Castro; Javier Canedo-Matute; Jessica Gomez-Cifuentes; Vilma M Rivas-Lemus; Kay J Park; Robert A Soslow; Esther Oliva; Raquel Valencia-Cedillo
Journal:  Am J Surg Pathol       Date:  2019-06       Impact factor: 6.394

9.  Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma.

Authors:  Elizabeth D Euscher; Anais Malpica; Edward Neely Atkinson; Charles F Levenback; Michael Frumovitz; Michael T Deavers
Journal:  Am J Surg Pathol       Date:  2008-09       Impact factor: 6.394

10.  The Prognostic Impact of Grading in FIGO IB and IIB Squamous Cell Cervical Carcinomas.

Authors:  Christine E Brambs; Anne Katrin Höhn; Bettina Hentschel; Uta Fischer; Karl Bilek; Lars-Christian Horn
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-02-18       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.